Figure 5.

Cact-3 reduced ocular surface damage and increased tear volume in a scopolamine-induced dry eye mouse model. (A) Representative photographs of mouse eyes (top) and corneal fluorescein staining images of mice (bottom). Vehicle and Cact-3 were treated 3 times a day for 10 days. (B) Summary of corneal fluorescein staining scores (mean ± S.E., n = 5). (C) Summary of basal tear volume measured with phenol red thread test (mean ± S.E., n = 8). NT: not treated; ns: not significant. * p < 0.05.